Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CURI
CURI logo

CURI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CuriosityStream Inc (CURI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.530
1 Day change
1.61%
52 Week Range
6.060
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CuriosityStream Inc (CURI) is not a strong buy for a beginner investor with a long-term focus at this time. The technical indicators show bearish trends, and there are no significant positive catalysts or trading signals to support an immediate purchase. While the stock has potential upside in the long term, the lack of strong financial data, recent news, or influential trades makes it prudent to hold off on investing until clearer positive signals emerge.

Technical Analysis

The technical indicators suggest a bearish trend. The MACD histogram is negative and contracting, RSI is neutral at 34.68, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 2.711, with key support at 2.48 and resistance at 2.942.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • The company's improving free cash flow since instituting a dividend is a positive sign, as noted by analysts.

Neutral/Negative Catalysts

  • Bearish technical indicators, lack of recent news, no significant hedge fund or insider trading activity, and no recent congress trading data. Additionally, the stock's licensing revenue is described as 'lumpy,' which may introduce uncertainty.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

The analyst rating remains Outperform, but the price target was lowered from $5.50 to $5, reflecting tempered expectations despite some positive cash flow developments.

Wall Street analysts forecast CURI stock price to rise
3 Analyst Rating
Wall Street analysts forecast CURI stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.490
sliders
Low
6
Averages
6
High
6
Current: 2.490
sliders
Low
6
Averages
6
High
6
Barrington
Patrick Sholl
Outperform
to
Outperform
downgrade
$5
AI Analysis
2026-05-15
Reason
Barrington
Patrick Sholl
Price Target
$5
AI Analysis
2026-05-15
downgrade
Outperform
to
Outperform
Reason
Barrington analyst Patrick Sholl lowered the firm's price target on CuriosityStream to $5 from $5.50 and keeps an Outperform rating on the shares. The company's licensing revenue is "lumpy" but its improving free cash flow since the dividend was instituted is encouraging, the analyst tells investors in a research note.
Barrington
Patrick Sholl
Outperform
to
NULL
downgrade
$6
2026-03-12
Reason
Barrington
Patrick Sholl
Price Target
$6
2026-03-12
downgrade
Outperform
to
NULL
Reason
Barrington analyst Patrick Sholl lowered the firm's price target on CuriosityStream to $5.50 from $6 and keeps an Outperform rating on the shares. The improving trajectory in free cash flow since the company instituted a dividend is "encouraging," says the analyst, who argues after the Q4 report that the company's expectation of additional opportunities to grow licensing revenues suggests that the increased dividend "may be sustainable."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CURI
Unlock Now

People Also Watch